Development of cell line derived organoids to evaluate stroma targeted therapies in pancreatic cancer

被引：0
|
作者：
Hall, Bradley
Santhamma, Bindu
Cannon, Andrew
Bhatia, Rakesh
Kumar, Sushil
Are, Chandrakanth
Nair, Hareesh
Nickisch, Klaus
Batra, Surinder
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5792
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5792
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Radiobiological Characterization of Pancreatic Cancer Patient-Derived Organoids
    Dobiasch, S.
    Kessler, C.
    Cadacio, F.
    Maurer, C.
    Schilling, D.
    Steiger, K.
    Schmid, R. M.
    Reichert, M.
    Combs, S. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E226 - E227
  • [32] Pateint Derived Breast Cancer Organoids as a Model for Testing Personalized Therapies
    Wajih, Nadeem
    Erali, Richard
    Forsythe, Steven
    Soker, Shay
    Votanopoulos, Konstantinos
    CANCER RESEARCH, 2023, 83 (05)
  • [33] Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer
    Nicolle, R.
    Gayet, O.
    Bigonnet, M.
    Roques, J.
    Chanez, B.
    Puleo, F.
    Augustin, J.
    Emile, J. F.
    Svrcek, M.
    Arsenijevic, T.
    Hammel, P.
    Rebours, V
    Giovannini, M.
    Grandval, P.
    Dahan, L.
    Moutardier, V
    Mitry, E.
    Van Laethem, J. L.
    Bachet, J. B.
    Cros, J.
    Iovanna, J.
    Dusetti, N. J.
    TRANSLATIONAL ONCOLOGY, 2022, 16
  • [34] Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
    Jaeger, Wolfgang
    Xue, Hui
    Hayashi, Tetsutaro
    Janssen, Claudia
    Awrey, Shannon
    Wyatt, Alexander W.
    Anderson, Shawn
    Moskalev, Igor
    Haegert, Anne
    Alshalalfa, Mohammed
    Erho, Nicholas
    Davicioni, Elai
    Fazli, Ladan
    Li, Estelle
    Collins, Colin
    Wang, Yuzhuo
    Black, Peter C.
    ONCOTARGET, 2015, 6 (25) : 21522 - 21532
  • [35] Molecular and pharmacological (EGFRi, MEKi) characterisation of a colorectal cancer (CRC) cell line panel to evaluate cellular phenotype and efficacy of targeted therapies in CRC
    Chresta, Christine M.
    Runswick, Sarah
    Beran, Garry
    Dayenport, Sara
    Callis, Rowena
    Wilkinson, Robert W.
    CANCER RESEARCH, 2011, 71
  • [36] Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
    Rabago, Dora Barbosa
    Blakely, Collin M.
    Haderk, Franziska
    Bivona, Trever G.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (177):
  • [37] Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma
    Kim, Seok-Young
    Kim, Sang-Min
    Lim, Sumin
    Lee, Ji Yeon
    Choi, Su-Jin
    Yang, San-Duk
    Yun, Mi Ran
    Kim, Chang Gon
    Gu, Seo Rin
    Park, Chaewon
    Park, A-Young
    Lim, Sun Min
    Heo, Seong Gu
    Kim, HyunKi
    Cho, Byoung Chul
    CLINICAL CANCER RESEARCH, 2021, 27 (15) : 4397 - 4409
  • [38] Development of new targeted therapies for breast cancer
    Doyle, Danielle M.
    Miller, Kathy D.
    BREAST CANCER, 2008, 15 (01) : 49 - 56
  • [39] Development of new targeted therapies for breast cancer
    Danielle M. Doyle
    Kathy D. Miller
    Breast Cancer, 2008, 15 : 49 - 56
  • [40] Biliary and pancreatic complications of molecular targeted therapies in cancer imaging
    Alessandrino, Francesco
    Krajewski, Katherine M.
    Tirumani, Sree Harsha
    Braschi-Amirfarzan, Marta
    Jagannathan, Jyothi P.
    Ramaiya, Nikhil H.
    Di Salvo, Donald N.
    ABDOMINAL RADIOLOGY, 2017, 42 (06) : 1721 - 1733
12345